Matches in Wikidata for { <http://www.wikidata.org/entity/Q85069930> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q85069930 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q85069930 description "im Oktober 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85069930 description "scientific article published on 04 October 2011" @default.
- Q85069930 description "wetenschappelijk artikel" @default.
- Q85069930 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q85069930 name "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 name "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 type Item @default.
- Q85069930 label "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 label "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 prefLabel "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 prefLabel "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 P1433 Q85069930-294FD31F-9CA2-404A-AC76-5B054106FDC6 @default.
- Q85069930 P1476 Q85069930-E7643010-A4D2-4D93-A93E-51CE448DDB9A @default.
- Q85069930 P2093 Q85069930-0A55EAB2-319D-4A6B-81F5-B97F60ED1AE9 @default.
- Q85069930 P2093 Q85069930-52A12AED-B20D-4CEA-9FFE-BCD8823139CD @default.
- Q85069930 P2093 Q85069930-94444F89-5C3D-452F-B040-078B7C107226 @default.
- Q85069930 P2093 Q85069930-A1EB7AD3-8E89-48E8-B40A-28DF7454C582 @default.
- Q85069930 P2093 Q85069930-B5EEC2CC-3AB7-4E25-8E98-5479577CF00A @default.
- Q85069930 P304 Q85069930-7AD611DC-1646-44ED-AE4B-38829643B010 @default.
- Q85069930 P31 Q85069930-1F763711-6803-47F0-BD2A-7B7B04BFC5B8 @default.
- Q85069930 P356 Q85069930-510221DB-F6A4-4421-ADE2-9375BF5613D0 @default.
- Q85069930 P433 Q85069930-7BD3B30D-511C-4065-BF39-9E817B99266D @default.
- Q85069930 P478 Q85069930-6FE6A290-D171-4EBE-A6B9-CE8535FCEB1F @default.
- Q85069930 P50 Q85069930-C0E7B075-5BDD-492E-B154-80ABDA20DBAF @default.
- Q85069930 P577 Q85069930-B39A60FC-7434-461F-BE35-C36823183DCB @default.
- Q85069930 P698 Q85069930-EDF32FA7-E18B-41D3-BD0F-16D818A0668D @default.
- Q85069930 P921 Q85069930-4291FA7A-6886-459A-8EC8-455BB5D147FC @default.
- Q85069930 P356 000330031 @default.
- Q85069930 P698 21986021 @default.
- Q85069930 P1433 Q15759132 @default.
- Q85069930 P1476 "Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients" @default.
- Q85069930 P2093 "Erdem Tüzün" @default.
- Q85069930 P2093 "Feza Deymeer" @default.
- Q85069930 P2093 "Piraye Oflazer" @default.
- Q85069930 P2093 "Vuslat Yılmaz" @default.
- Q85069930 P2093 "Yeşim Parman" @default.
- Q85069930 P304 "581-583" @default.
- Q85069930 P31 Q13442814 @default.
- Q85069930 P356 "10.1159/000330031" @default.
- Q85069930 P433 "6" @default.
- Q85069930 P478 "20" @default.
- Q85069930 P50 Q87103739 @default.
- Q85069930 P577 "2011-10-04T00:00:00Z" @default.
- Q85069930 P698 "21986021" @default.
- Q85069930 P921 Q8285 @default.